Diversity, Equity, and Inclusion in Hematology
Commitment to Diversity,
Equity, and Inclusion
As a global hematology community, ASH understands the importance of having individuals with diverse perspectives and experiences in all areas of the field. Through various ASH programs and committees, ASH continues its long-standing commitment to combating inequities in hematology, supporting scientists and clinicians from backgrounds underrepresented in medicine, and embracing diverse voices across the patient and health care communities. ASH stands in solidarity with our members and patients in communities that are targets of discrimination, harassment, and violence, and remains committed to combatting all forms of bigotry.
ASH Inclusion Program Retained and Engaged Hematologists Underrepresented in Field, 20-Year Analysis Shows
Participants of the ÎÚÑ»´«Ã½ (ASH) Minority Recruitment Initiative had lower attrition rates in graduate and medical programs, were more likely to pursue a career in hematology, and had high levels of engagement at ASH beyond their participation in the program, according to a study published in .
Our Approach
ASH is committed to diversity and inclusion and encourages the engagement and participation of individuals
regardless of their race, ethnicity, religion, age, sexual orientation, gender identity or expression, ability, national
origin, or other attributes. This commitment follows a four-pronged approach:
Pathways
Inspiring, recruiting, and supporting researchers and clinicians from diverse backgrounds to pursue and excel in careers in hematology and related fields.
Workforce Diversity
Involving people with diverse perspectives, talents, and experiences in leadership, volunteer, and staff positions.
Equity in Care
Advocating for policies and supporting programs aimed at eliminating health disparities in hematology patient care.
Absolute Neutrophil Count (ANC)
Reference Ranges by Duffy Status
The Duffy-null Associated Neutrophil Count (DANC) is a two-year health equity project focused on improving care for individuals with the Duffy-null phenotype, characterized by the absence of the Duffy antigen on red blood cells. The project seeks to enhance understanding of DANC and its impact, from clinical trials to patient care. To achieve this, the initiative aims to empower health care systems, educate professionals, and implement population-level interventions. This project is funded by a grant from the .
Resources
ASH’s innovative and impactful DEI programming and resources provide valuable opportunities
for education and help shape a new cultural framework for the next generation of hematologists.
ASH DEI Toolkit for Clinical Trial Sponsors
This guide is designed to help trial sponsors incorporate DEI principles throughout the trial life cycle. It includes actionable recommendations, reference articles, and additional resources from both national and international regulatory bodies and research organizations.
